Bank Of New York Mellon Corp Regenxbio Inc. Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$20.4 - $24.73 $7.32 Million - $8.88 Million	358,957 New	358,957 $8.14 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $104,651 - $164,512	4,695 Added 1.4%	340,056 $8.99 Million
Q2 2022 Aug 15, 2022	SELL	$19.35 - $35.04 $180,148 - $326,222	-9,310 Reduced 2.7%	335,361 $8.28 Million
Q1 2022 May 11, 2022	BUY	$24.62 - $34.31 $22,675 - $31,599	921 Added 0.27%	344,671 $11.4 Million
Q4 2021 Feb 11, 2022	BUY	$30.19 - $40.28 $147,236 - $196,445	4,877 Added 1.44%	343,750 $11.2 Million
Q3 2021 Nov 12, 2021	BUY	$29.09 - $45.68 $548,899 - $861,935	18,869 Added 5.9%	338,873 $14.2 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $40.48 $945,527 - $1.18 Million	-29,129 Reduced 8.34%	320,004 $12.4 Million
Q1 2021 May 13, 2021	BUY	$33.61 - $49.95 $1.16 Million - $1.72 Million	34,402 Added 10.93%	349,133 $11.9 Million
Q4 2020 Feb 09, 2021	SELL	$26.52 - $49.35 $217,066 - $403,929	-8,185 Reduced 2.53%	314,731 $14.3 Million
Q3 2020 Nov 12, 2020	SELL	$27.01 - $40.26 $687,215 - $1.02 Million	-25,443 Reduced 7.3%	322,916 $8.89 Million
Q2 2020 Aug 12, 2020	SELL	$27.75 - $43.44 $27,167 - $42,527	-979 Reduced 0.28%	348,359 $12.8 Million
Q1 2020 May 06, 2020	SELL	$21.5 - $54.2 $27,477 - $69,267	-1,278 Reduced 0.36%	349,338 $11.3 Million
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $1.77 Million - $2.3 Million	-51,321 Reduced 12.77%	350,616 $14.4 Million
Q3 2019 Nov 07, 2019	SELL	$31.84 - $50.88 $4.72 Million - $7.54 Million	-148,288 Reduced 26.95%	401,937 $14.3 Million
Q2 2019 Aug 12, 2019	SELL	$42.0 - $59.29 $5.07 Million - $7.16 Million	-120,770 Reduced 18.0%	550,225 $28.3 Million
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $5.72 Million - $8.75 Million	140,087 Added 26.39%	670,995 $38.5 Million
Q4 2018 Feb 11, 2019	BUY	$39.11 - $75.15 $6.71 Million - $12.9 Million	171,493 Added 47.71%	530,908 $22.3 Million
Q3 2018 Nov 09, 2018	BUY	$65.0 - $82.15 $2.61 Million - $3.29 Million	40,085 Added 12.55%	359,415 $0
Q2 2018 Aug 06, 2018	BUY	$27.2 - $74.35 $5.08 Million - $13.9 Million	186,595 Added 140.58%	319,330 $22.9 Million
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $99,446 - $155,062	-4,135 Reduced 3.02%	132,735 $3.96 Million
Q4 2017 Feb 09, 2018	BUY	$26.0 - $34.6 $3.56 Million - $4.74 Million	136,870	136,870 $4.55 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account